Literature DB >> 21326590

Endovascular therapy for palliative care of cancer patients.

Kush R Desai1, Richard I Chen.   

Abstract

Interventional radiology procedures often play an integral role in the diagnosis and treatment of patients with cancer. In the latter stages of cancer treatment, palliative care therapies may be sought for improvement in the quality of remaining life for oncology patients. Increased awareness among interventionalists and referring oncologists regarding minimally invasive treatments for palliation is desirable to provide additional options for patients. In particular, endovascular therapies can provide control of symptoms and complications related to incurable malignancies.

Entities:  

Keywords:  Palliative care; endovascular therapy; interventional radiology

Year:  2007        PMID： 21326590      PMCID： PMC3037249          DOI： 10.1055/s-2007-992326

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


  31 in total

1.  Palliative transarterial embolization of renal tumors in 20 patients.

Authors:  Laurent Guy; Agaïcha T Alfidja; Pascal Chabrot; Anne Ravel; Jean-Paul Boiteux; Louis Boyer
Journal:  Int Urol Nephrol       Date:  2007-02-20       Impact factor: 2.370

2.  Treatment of ruptured hepatocellular carcinoma.

Authors:  A Tanaka; R Takeda; S Mukaihara; K Hayakawa; T Shibata; K Itoh; N Nishida; K Nakao; Y Fukuda; T Chiba; Y Yamaoka
Journal:  Int J Clin Oncol       Date:  2001-12       Impact factor: 3.402

3.  Embolization of bone metastases.

Authors:  P P Barton; R E Waneck; F J Karnel; P Ritschl; J Kramer; G L Lechner
Journal:  J Vasc Interv Radiol       Date:  1996 Jan-Feb       Impact factor: 3.464

4.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

5.  Embolization for hemorrhage of liver metastases from choriocarcinoma.

Authors:  C A R Lok; J A Reekers; A M Westermann; J Van der Velden
Journal:  Gynecol Oncol       Date:  2005-09       Impact factor: 5.482

6.  Endovascular treatment of superior vena cava obstruction in patients with malignancies.

Authors:  F Thony; D Moro; P Witmeyer; S Angiolini; C Brambilla; M Coulomb; G Ferretti
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

Review 7.  Clinical manifestations of carcinoid disease.

Authors:  N D Bax; H F Woods; A Batchelor; M Jennings
Journal:  World J Surg       Date:  1996-02       Impact factor: 3.352

8.  [Preoperative and palliative embolization of renal cell carcinomas: follow-up of 49 patients].

Authors:  P Hallscheidt; S Besharati; G Noeldge; A Haferkamp; R Lopez; G W Kauffmann
Journal:  Rofo       Date:  2006-04

9.  Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma.

Authors:  C F A Eustatia-Rutten; J A Romijn; M J Guijt; G J Vielvoye; R van den Berg; E P M Corssmit; A M Pereira; J W A Smit
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

10.  Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.

Authors:  Scott R Schell; E Ramsay Camp; James G Caridi; Irvin F Hawkins
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452
View more
  3 in total

Review 1.  Palliative procedures in lung cancer.

Authors:  Emi Masuda; Akhilesh K Sista; Bradley B Pua; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 2.  The Intersection of Palliative Care and Interventional Radiology: Enhancing Understanding and Collaboration.

Authors:  Mary K Buss
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

3.  Application of manual aspiration thrombectomy in the treatment of deep vein thrombosis in cancer patients: Descriptive retrospective cohort study.

Authors:  Eu Hyun Kim; Hae Giu Lee; Jung Suk Oh; Ho Jong Chun; Byung Gil Choi; Myung Ah Lee
Journal:  PLoS One       Date:  2021-08-04       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.